PRC Impact conducted qualitative research with prescribers to understand how clinical communications, labeling, and decision tools for a prescription anti-inflammatory align with the rhythm of actual practice.
The work informed message design for materials prescribers needed to use under time pressure.
Clinical materials are often built around what should be communicated.
The research question was simpler and more useful: what actually gets through?
What language, structure, and emphasis hold up when a clinician has minutes, not hours, to decide?
Senior-led in-depth interviews with prescribers across practice settings, designed to surface how clinicians read, prioritize, and act on the materials in front of them.
Recruitment focused on practitioners actively using the materials in real clinical workflows, not advisors reviewing them in the abstract.
Conversations followed the clinician's actual decision process, not the institution's intended one.
The research surfaced patterns in how structure and sequencing affected what clinicians retained under time pressure.
Where materials front-loaded the clinical context, prescribers moved through them more efficiently.
Where language mirrored institutional framing rather than clinical practice, it created friction and got skipped.
The findings informed targeted revisions without overhauling the underlying clinical content.
Better communications start with how the audience actually reads them, not how the institution wishes they would.
This engagement is summarized without identifying the client, product, or proprietary materials because the work involved confidential health communications strategy.